Neogen Corp
NASDAQ:NEOG

Watchlist Manager
Neogen Corp Logo
Neogen Corp
NASDAQ:NEOG
Watchlist
Price: 9.275 USD -1.85%
Market Cap: $2B

P/B

1
Current
7%
Cheaper
vs 3-y average of 1

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
1
=
Market Cap
$2.1B
/
Total Equity
$2.1B

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
1
=
Market Cap
$2.1B
/
Total Equity
$2.1B

Valuation Scenarios

Neogen Corp is trading below its 3-year average

If P/B returns to its 3-Year Average (1), the stock would be worth $10.01 (8% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+225%
Average Upside
105%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 1 $9.28
0%
3-Year Average 1 $10.01
+8%
5-Year Average 1.2 $11.55
+25%
Industry Average 3.1 $30.15
+225%
Country Average 2.5 $24.28
+162%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close
Market Cap P/B P/E
US
Neogen Corp
NASDAQ:NEOG
2.1B USD 1 -3.3
JP
Hoya Corp
TSE:7741
9.9T JPY 9.6 39.6
US
Medline Inc
NASDAQ:MDLN
59.4B USD 0 0
CH
Alcon AG
SIX:ALC
29.2B CHF 1.7 37.2
DK
Coloplast A/S
CSE:COLO B
91B DKK 6.7 23.2
US
Align Technology Inc
NASDAQ:ALGN
13.2B USD 3.1 30.9
UK
ConvaTec Group PLC
LSE:CTEC
4.3B GBP 3.7 32.5
JP
Asahi Intecc Co Ltd
TSE:7747
905.8B JPY 5.7 51.2
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD 0.9 -15.6
KR
HLB Inc
KOSDAQ:028300
8.2T KRW 19.6 -37.2
CN
Intco Medical Technology Co Ltd
SZSE:300677
37.7B CNY 2.1 22.2
P/E Multiple
Earnings Growth PEG
US
Neogen Corp
NASDAQ:NEOG
Average P/E: 33.8
Negative Multiple: -3.3
N/A N/A
JP
Hoya Corp
TSE:7741
39.6
15%
2.6
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
CH
Alcon AG
SIX:ALC
37.2
32%
1.2
DK
Coloplast A/S
CSE:COLO B
23.2
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
30.9
34%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
32.5
41%
0.8
JP
A
Asahi Intecc Co Ltd
TSE:7747
51.2
40%
1.3
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.6 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -37.2 N/A N/A
CN
Intco Medical Technology Co Ltd
SZSE:300677
22.2
12%
1.8

Market Distribution

Lower than 86% of companies in the United States of America
Percentile
14th
Based on 10 946 companies
14th percentile
1
Low
0 — 1.5
Typical Range
1.5 — 4.8
High
4.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 1.5
Median 2.5
70th Percentile 4.8
Max 147 580.5

Neogen Corp
Glance View

Market Cap
2B USD
Industry
Health Care

Founded in 1982, Neogen Corp. has steadily carved out its niche at the intersection of food safety and animal health, positioning itself as a vital player in agricultural diagnostics. The company's journey began in Lansing, Michigan, where it initially focused on innovative solutions to meet the growing demands of food safety and quality testing. By developing rapid tests for detecting foodborne bacteria and allergens, Neogen tapped into a critical market, addressing the increasing concerns about food safety amidst a complex global supply chain. This foundation in diagnostics set the stage for the growth Neogen would see over the ensuing decades. As Neogen expanded, it strategically diversified its offerings, moving beyond food safety into the broader realm of animal health. This expansion was not merely about developing products; it was about advancing the means by which farms and food producers monitor and ensure the health of their livestock and crops. The company's profits flow from the sale of its diagnostic products, which help minimize risks associated with food contamination and animal diseases. By providing a suite of solutions, from DNA testing for genetic traits and diseases in cattle to disinfectants and rodenticides that maintain farm hygiene, Neogen creates value for its clients by increasing their operational efficiency and safeguarding public health. This strategic blend of food safety and animal health products places Neogen at the heart of modern agricultural and food production systems, where safety and efficiency are paramount.

NEOG Intrinsic Value
6.635 USD
Overvaluation 28%
Intrinsic Value
Price $9.275
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett